title: Interaction of Interferon gamma-induced reactive oxygen species with ceftazidime leads to synergistic killing of intracellular Burkholderia pseudomallei.
abstract: Burkholderia pseudomallei, a facultative intracellular pathogen, causes severe infections and is inherently refractory to many antibiotics. Previous studies from our group have shown that interferon gamma (IFN-γ) interacts synergistically with the antibiotic ceftazidime to kill bacteria in infected macrophages. The present study aimed to identify the underlying mechanism of that interaction. We first showed that blocking reactive oxygen species (ROS) pathways reversed IFN-γ- and ceftazidime-mediated killing, which led to our hypothesis that IFN-γ-induced ROS interacted with ceftazidime to synergistically kill Burkholderia bacteria. Consistent with this hypothesis, we also observed that buthionine sulfoximine (BSO), another inducer of ROS, could substitute for IFN-γ to similarly potentiate the effect of ceftazidime on intracellular killing. Next, we observed that IFN-γ induced ROS-mediated killing of intracellular but not extracellular bacteria. On the other hand, ceftazidime effectively reduced extracellular bacteria but was not capable of intracellular killing when applied at 10 μg/ml. We investigated the exact role of IFN-γ-induced ROS responses on intracellular bacteria and notably observed a lack of actin polymerization associated with Burkholderia bacteria in IFN-γ-treated macrophages, which led to our finding that IFN-γ-induced ROS blocks vacuolar escape. Based on these results, we propose a model in which synergistically reduced bacterial burden is achieved primarily through separate and compartmentalized killing: intracellular killing by IFN-γ-induced ROS responses and extracellular killing by ceftazidime. Our findings suggest a means of enhancing antibiotic activity against Burkholderia bacteria through combination with drugs that induce ROS pathways or otherwise target intracellular spread and/or replication of bacteria.
authors: Regional Center of Excellence in Emerging Diseases and Bioterrorism, Department of Microbiology, Immunology, and Pathology, Colorado State University, Ft. Collins, Colorado, USA.
authors: Kara
authors: K
authors: Mosovsky
authors: Regional Center of Excellence in Emerging Diseases and Bioterrorism, Department of Microbiology, Immunology, and Pathology, Colorado State University, Ft. Collins, Colorado, USA.
authors: Ediane
authors: E
authors: Silva
authors: Regional Center of Excellence in Emerging Diseases and Bioterrorism, Department of Microbiology, Immunology, and Pathology, Colorado State University, Ft. Collins, Colorado, USA.
authors: Ryan
authors: R
authors: Troyer
authors: Regional Center of Excellence in Emerging Diseases and Bioterrorism, Department of Microbiology, Immunology, and Pathology, Colorado State University, Ft. Collins, Colorado, USA.
authors: Katie
authors: K
authors: Propst-Graham
authors: Regional Center of Excellence in Emerging Diseases and Bioterrorism, Department of Microbiology, Immunology, and Pathology, Colorado State University, Ft. Collins, Colorado, USA sdow@colostate.edu.
authors: Steven
authors: S
authors: Dow
mesh_terms: D000818:Animals; D016957:Burkholderia pseudomallei / Q000187:drug effects*; D002442:Ceftazidime / Q000737:chemistry / Q000494:pharmacology*; D002460:Cell Line; D002478:Cells, Cultured; D005260:Female; D005434:Flow Cytometry; D007371:Interferon-gamma / Q000494:pharmacology*; D008264:Macrophages; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008813:Mice, Inbred ICR; D008856:Microscopy, Fluorescence; D017382:Reactive Oxygen Species / Q000737:chemistry / Q000378:metabolism*
chemical_list: D017382:Reactive Oxygen Species; D007371:Interferon-gamma; D002442:Ceftazidime